UGC Approved Journal no 63975(19)
New UGC Peer-Reviewed Rules

ISSN: 2349-5162 | ESTD Year : 2014
Volume 13 | Issue 3 | March 2026

JETIREXPLORE- Search Thousands of research papers



WhatsApp Contact
Click Here

Published in:

Volume 11 Issue 12
December-2024
eISSN: 2349-5162

UGC and ISSN approved 7.95 impact factor UGC Approved Journal no 63975

7.95 impact factor calculated by Google scholar

Unique Identifier

Published Paper ID:
JETIR2412711


Registration ID:
553130

Page Number

h83-h88

Share This Article


Jetir RMS

Title

'Comparative Efficacy Of Manjistha Churna As Phant And Bhumyamlaki Churna In The Management Of Fatty Liver Disease: An Ayurvedic Perspective'

Abstract

Abstract Objective: This study aimed to evaluate and compare the efficacy of two Ayurvedic drugs, Manjistha Churna as Phant and Bhumyamlaki Churna, in managing fatty liver disease (Medagni-Mandya janya Medodushti). Methods: A total of 60 patients diagnosed with fatty liver disease (Grade I–III) were enrolled and randomly assigned into two groups: Group A (Manjistha Churna as Phant, 10 g/day, orally for 45 days) and Group B (Bhumyamlaki Churna, 5 g twice daily, orally for 45 days). The main assessment parameter included changes in liver fat content evaluated by abdominal ultrasonography (USG) and improvements in clinical symptoms such as hyperacidity, flatulence, heaviness in the abdomen, constipation, anorexia, and abdominal pain. Statistical analyses were performed using the Wilcoxon matched-pairs signed-ranks test and paired t-tests. Results: Both groups demonstrated statistically significant improvements in USG scores, with reductions in fatty liver grades (Group A: mean difference 0.7333, p < 0.0001; Group B: mean difference 0.7667, p < 0.0001). Symptom relief was observed across all parameters in both groups, with hyperacidity showing notable improvement (Group A: 70.09% relief, Group B: 77.22% relief). Group A exhibited slightly better symptom control in hyperacidity and heaviness in the abdomen, while Group B showed marginally superior outcomes in reducing anorexia and fat content. However, intergroup comparisons revealed no statistically significant differences in overall efficacy (p > 0.05). Conclusion: Both Manjistha Churna as Phant and Bhumyamlaki Churna are effective in managing fatty liver disease, offering significant reductions in symptoms and liver fat grades. While their efficacy profiles are comparable, specific symptom-oriented benefits may guide tailored therapeutic approaches.

Key Words

Fatty Liver Disease, Manjistha Churna, Bhumyamlaki Churna

Cite This Article

"'Comparative Efficacy Of Manjistha Churna As Phant And Bhumyamlaki Churna In The Management Of Fatty Liver Disease: An Ayurvedic Perspective'", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.11, Issue 12, page no.h83-h88, December-2024, Available :http://www.jetir.org/papers/JETIR2412711.pdf

ISSN


2349-5162 | Impact Factor 7.95 Calculate by Google Scholar

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 7.95 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Cite This Article

"'Comparative Efficacy Of Manjistha Churna As Phant And Bhumyamlaki Churna In The Management Of Fatty Liver Disease: An Ayurvedic Perspective'", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.11, Issue 12, page no. pph83-h88, December-2024, Available at : http://www.jetir.org/papers/JETIR2412711.pdf

Publication Details

Published Paper ID: JETIR2412711
Registration ID: 553130
Published In: Volume 11 | Issue 12 | Year December-2024
DOI (Digital Object Identifier):
Page No: h83-h88
Country: jaipur, rajasthan, India .
Area: Medical Science
ISSN Number: 2349-5162
Publisher: IJ Publication


Preview This Article


Downlaod

Click here for Article Preview

Download PDF

Downloads

000273

Print This Page

Current Call For Paper

Jetir RMS